Case number 1:18-cv-01673
Anacor Pharmaceuticals, Inc. v. Ascent Pharmaceuticals, Inc. et al > Documents
| Date Field | Doc. No. | Description (Pages) |
|---|---|---|
| Sep 11, 2020 | 139 | Judgment (3) Docket Text: FINAL JUDGMENT is entered in favor of Defendants and against Anacor on Anacor's claims of infringement, and on Defendants' counterclaims of invalidity (see Judgment for further details) (CASE CLOSED). Signed by Judge Richard G. Andrews on 9/11/2020. Associated Cases: 1:19-md-02884-RGA, 1:18-cv-01606-RGA, 1:18-cv-01673-RGA(nms) |
| Sep 11, 2020 | 140 | Main Document (1) Docket Text: Report to the Commissioner of Patents and Trademarks for Patent/Trademark Number(s) 9,459,938 B2; 9,566,289 B2; 9,566,290 B2; 9,572,823 B2. (Attachments: # (1) Judgment)(nms) |
| Sep 11, 2020 | 140 | Judgment (3) |
| Sep 10, 2020 | 138 | Main Document (3) Docket Text: PROPOSED Final Judgment, by Anacor Pharmaceuticals, Inc.. (Attachments: # (1) Letter)(Dellinger, Megan) Modified on 9/11/2020 (nms). |
| Sep 10, 2020 | 138 | Letter to Judge Andrews (1) |
| Aug 31, 2020 | 137 | Notice (Other) (4) Docket Text: Joint NOTICE of Federal Circuit Decision by Anacor Pharmaceuticals, Inc. (Dellinger, Megan) |
| Jul 9, 2020 | 99 | Motion for Leave to Appear Pro Hac Vice (2) |
| Jul 9, 2020 | 57 | Motion for Leave to Appear Pro Hac Vice (2) |
| Dec 27, 2019 | 136 | Notice of Appearance (1) Docket Text: NOTICE of Appearance by Damien Nicholas Tancredi on behalf of Cipla Limited, Cipla USA, Inc. (Tancredi, Damien) |
| Dec 16, 2019 | 135 | Notice Requesting Removal of Co-Counsel (3) Docket Text: NOTICE requesting Clerk to remove Paul B. Sudentas as co-counsel. Reason for request: no longer with Locke Lord LLP. (Kraman, Pilar) |
| Sep 19, 2019 | 133 | Order (3) Docket Text: ORDER TO STAY: The actions are stayed pending Plaintiff's appeal of the PTAB Decisions to the Federal Circuit. The parties will notify the Court of the Federal Circuit's decision no later than three (3) days after it issues. The parties should be prepared to submit with the notification their requests for how to proceed. Signed by Judge Richard G. Andrews on 9/19/2019. Associated Cases: 1:19-md-02884-RGA, 1:18-cv-01606-RGA, 1:18-cv-01673-RGA, 1:19-cv-00632-RGA(nms) |
| Sep 19, 2019 | 134 | Order Administratively Closing Case (2) Docket Text: ORDER: The cases are ADMINISTRATIVELY CLOSED. The parties shall promptly notify the Court when the "Federal Circuit" has resolved the appeal so that these case may be reopened and other appropriate action may be taken. Signed by Judge Richard G. Andrews on 9/19/2019. Associated Cases: 1:19-md-02884-RGA, 1:18-cv-01606-RGA, 1:18-cv-01673-RGA, 1:19-cv-00632-RGA(nms) |
| Sep 13, 2019 | 131 | Letter (4) |
| Sep 13, 2019 | 131 | Exhibit 1-2 (7) |
| Sep 13, 2019 | 132 | Letter (9) |
| Sep 13, 2019 | 132 | Text of Proposed Order (4) |
| Sep 13, 2019 | 131 | Main Document (4) Docket Text: Letter to The Honorable Richard G. Andrews from Megan E. Dellinger regarding Proposed Stay. (Attachments: # (1) Exhibit 1-2)(Dellinger, Megan) |
| Sep 13, 2019 | 132 | Main Document (9) Docket Text: Letter to Honorable Richard G. Andrews from Kelly E. Farnan regarding Defendants' Support of Their Stay Proposal. (Attachments: # (1) Text of Proposed Order)(Farnan, Kelly) |
| Aug 27, 2019 | 130 | Order (5) Docket Text: ORDER re (71 in 19-cv-632-RGA, 129 in 18-cv-1673-RGA, 86 in 18-cv-1606-RGA, 62 in 19-md-2884-RGA) Stipulation and Order to File Competing Stay Proposals. Signed by Judge Richard G. Andrews on 8/27/2019. Associated Cases: 1:19-md-02884-RGA, 1:18-cv-01606-RGA, 1:18-cv-01673-RGA, 1:19-cv-00632-RGA(nms) |
| Aug 26, 2019 | 129 | Stipulation (5) Docket Text: STIPULATION and [Proposed] Order to File Competing Stay Proposals by Taro Pharmaceutical Industries, Ltd., Taro Pharmaceuticals U.S.A., Inc., Encube Ethicals Pvt. Ltd.. (Farnan, Kelly) |
| Aug 20, 2019 | N/A | SO ORDERED (0) Docket Text: SO ORDERED, re (128 in 18-cv-1673-RGA, 85 in 18-cv-1606-RGA, 70 in 19-cv-632-RGA, 61 in 19-md-2884-RGA) Stipulation and Order to Amend Scheduling Order. Signed by Judge Richard G. Andrews on 8/15/2019. Associated Cases: 1:19-md-02884-RGA, 1:18-cv-01606-RGA, 1:18-cv-01673-RGA, 1:19-cv-00632-RGA(nms) |
| Aug 14, 2019 | 128 | Stipulation (5) Docket Text: STIPULATION and Order to Amend Scheduling Order by Anacor Pharmaceuticals, Inc., Anacor Pharmaceuticals, Inc.. (Dellinger, Megan) |
| Aug 8, 2019 | N/A | SO ORDERED (0) |
| Aug 7, 2019 | 127 | Stipulation (7) Docket Text: STIPULATION to Amend Scheduling Order by Cadila Healthcare Ltd., Zydus Pharmaceuticals (USA) Inc.. (Kraman, Pilar) |
| Jul 31, 2019 | N/A | SO ORDERED (0) |
| Jul 31, 2019 | 126 | Stipulation to EXTEND Time (7) Docket Text: STIPULATION TO EXTEND TIME to submit Protective Order to August 14, 2019 - filed by Taro Pharmaceutical Industries, Ltd., Taro Pharmaceuticals U.S.A., Inc., Encube Ethicals Pvt. Ltd.. (Farnan, Kelly) Modified on 8/1/2019 (nms). |
| Jul 25, 2019 | N/A | SO ORDERED (0) |
| Jul 24, 2019 | 124 | Notice of Service (3) Docket Text: NOTICE OF SERVICE of core technical documents (bates numbers ASC-TAV0000001-0002838) filed by Ascent Pharmaceuticals, Inc..(Rogowski, Patricia) |
| Jul 24, 2019 | 125 | Stipulation (7) Docket Text: STIPULATION and Order to Amend Scheduling Order by Lupin Limited, Lupin Pharmaceuticals, Inc.. (Mowery, Katharine) |
| Jul 23, 2019 | 123 | Notice of Substitution of Counsel (2) Docket Text: NOTICE OF SUBSTITUTION OF COUNSEL re Ascent Pharmaceuticals, Inc.: Entry of appearance of attorney Patricia Smink Rogowski. Attorney R. Touhey Myer and Salvatore Guerriero terminated. (Rogowski, Patricia) |
| Jul 17, 2019 | N/A | SO ORDERED (0) |
| Jul 16, 2019 | 122 | Stipulation to EXTEND Time (7) Docket Text: STIPULATION TO EXTEND TIME to file a protective order to July 31, 2019 - filed by Mylan Inc., Mylan Pharmaceuticals Inc.. (Palapura, Bindu) Modified on 7/17/2019 (nms). |
| Jun 26, 2019 | N/A | Order (0) |
| Jun 26, 2019 | 120 | Notice of Service (2) Docket Text: NOTICE OF SERVICE of (1) Apotex's Initial Disclosures Pursuant to Fed. R. Civ. P. 26(a)(1); and (2) Apotex's Initial Disclosures Pursuant to Paragraph 3 of the Default Standard for Discovery filed by Apotex Corp., Apotex Inc..(Haney, Megan) |
| Jun 26, 2019 | 121 | Notice (Other) (2) Docket Text: NOTICE of Withdrawal of Counsel, Michelle M. Ovanesian by Perrigo Company plc, Perrigo Pharma International DAC (Higgins, James) |
| Jun 25, 2019 | 119 | Stipulation (8) Docket Text: STIPULATION and Order to Amend Scheduling Order by Mylan Inc., Mylan Pharmaceuticals Inc.. (Palapura, Bindu) |
| Jun 14, 2019 | N/A | SO ORDERED (0) |
| Jun 13, 2019 | N/A | SO ORDERED (0) |
| Jun 13, 2019 | N/A | SO ORDERED (0) |
| Jun 13, 2019 | N/A | Add Attorneys Pro Hac Vice (0) Docket Text: Pro Hac Vice Attorney Joseph M. Janusz for Apotex Corp., for Apotex Inc. added for electronic noticing. Pursuant to Local Rule 83.5 (d)., Delaware counsel shall be the registered users of CM/ECF and shall be required to file all papers. (myr) |
| Jun 13, 2019 | 116 | Stipulation to EXTEND Time (9) Docket Text: STIPULATION TO EXTEND TIME Proposed Protective Order to and including June 27, 2019 - filed by Taro Pharmaceutical Industries, Ltd., Taro Pharmaceuticals U.S.A., Inc., Encube Ethicals Pvt. Ltd.. (Farnan, Kelly) |
| Jun 13, 2019 | 117 | Stipulation to EXTEND Time (2) Docket Text: STIPULATION TO EXTEND TIME for Paragraph 3 Default Standard Disclosures and Rule 26(a) Initial Disclosures to June 27, 2019 - filed by Apotex Corp., Apotex Inc.. (Haney, Megan) |
| Jun 13, 2019 | 118 | Motion for Leave to Appear Pro Hac Vice (3) Docket Text: MOTION for Pro Hac Vice Appearance of Attorney Joseph M. Janusz - filed by Apotex Corp., Apotex Inc.. (Haney, Megan) |
| Jun 7, 2019 | 115 | Notice (Other) (3) Docket Text: NOTICE of Withdrawal of Christine M. Braswell as Counsel by Cadila Healthcare Ltd., Zydus Pharmaceuticals (USA) Inc. (Kraman, Pilar) |
| Jun 4, 2019 | 114 | Order (2) Docket Text: SO ORDERED Granting (40 in 19-md-2884-RGA, 113 in 18-cv-1673-RGA) Stipulation of Dismissal (*Parties Aurobindo Pharma Limited and Aurobindo Pharma USA, Inc., terminated). Signed by Judge Richard G. Andrews on 6/3/2019. Associated Cases: 1:19-md-02884-RGA, 1:18-cv-01673-RGA(nms) |
| May 31, 2019 | N/A | SO ORDERED (0) |
| May 31, 2019 | N/A | CORRECTING ENTRY: (0) Docket Text: CORRECTING ENTRY: The pdf for D.I. [104] has been replaced with an amended version. The caption on the filing has been corrected. (nms) |
| May 31, 2019 | 112 | Notice of Service (2) Docket Text: NOTICE OF SERVICE of (1) Initial Disclosures under Rule 26(a)(1) and (2) Initial Disclosures under Paragraph 3 of the Default Standard for Discovery filed by Cipla Limited, Cipla USA, Inc..(Cole, Jeremy) |
| May 31, 2019 | 113 | Stipulation of Dismissal (2) Docket Text: STIPULATION of Dismissal by Aurobindo Pharma Limited, Aurobindo Pharma USA, Inc.. (Dorsney, Kenneth) |
| May 30, 2019 | N/A | SO ORDERED (0) |
| May 30, 2019 | 103 | Stipulation to EXTEND Time (2) Docket Text: STIPULATION TO EXTEND TIME deadlines for Paragraph 3 Default Standard Disclosures and Rule 26(a) Initial Disclosures to June 13, 2019 - filed by Apotex Corp., Apotex Inc.. (Haney, Megan) |
| May 30, 2019 | 104 | Notice of Service (2) Docket Text: NOTICE OF SERVICE of Ascent Pharm., Inc.s Disclosures Pursuant to Paragraph 3 of the Delaware Default Standard for Discovery and Ascent Pharm., Inc.s Disclosures Pursuant to Fed. R. Civ. P. 26(a)(1) filed by Ascent Pharmaceuticals, Inc..(Myer, R.) (Main Document 104 replaced on 5/31/2019) (nms). |
| May 30, 2019 | 105 | Notice of Service (2) Docket Text: NOTICE OF SERVICE of Defendant Aleor Dermaceuticals Limiteds Initial Disclosures Pursuant to Delawares Default Standard for Discovery and Defendant Aleor Dermaceuticals Limiteds Initial Disclosures filed by Aleor Dermaceuticals Limited.(Harmon, Kate) |
| May 30, 2019 | 106 | Stipulation to EXTEND Time (7) Docket Text: STIPULATION TO EXTEND TIME Deadline for the Parties to Submit a Proposed Protective Order to June 13, 2019 - filed by Perrigo Company plc, Perrigo Pharma International DAC. (Ovanesian, Michelle) |
| May 30, 2019 | 107 | Notice of Service (2) Docket Text: NOTICE OF SERVICE of Initial Disclosures of Perrigo Pharma International DAC and Perrigo Company plc filed by Perrigo Company plc, Perrigo Pharma International DAC.(Ovanesian, Michelle) |
| May 30, 2019 | 108 | Notice of Service (18) Docket Text: NOTICE OF SERVICE of (1) Anacor's Rule 26(a) Initial Disclosures and (2) Anacor's Initial Disclosures Pursuant to Paragraph 3 of the Delaware Default Standard for Discovery filed by Anacor Pharmaceuticals, Inc..(Dellinger, Megan) |
| May 30, 2019 | 109 | Notice of Service (2) Docket Text: NOTICE OF SERVICE of 1) Defendant Amneal Pharmaceuticals LLC's Initial Disclosures Under Paragraph 3 of the District of Delaware's Default Standard for Discovery, Including Electronically Stored Information ("ESI") and 2) Defendant Amneal Pharmaceuticals LLC's Initial Disclosures Pursuant to Rule 26(a)(1) filed by Amneal Pharmaceuticals LLC.(Gaza, Anne) |
| May 30, 2019 | 110 | Notice of Service (2) Docket Text: NOTICE OF SERVICE of (1) Defendants Taro Pharmaceuticals U.S.A. and Taro Pharmaceutical Industries, Ltd. Initial Disclosures Under Rule 26(a)(1) and (2) Defendants Taro Pharmaceutical Industries, Ltd. and Taro Pharmaceuticals U.S.A., Inc.'s Initial Disclosures Under Paragraph 3 of the Default Standard for Discovery filed by Taro Pharmaceutical Industries, Ltd., Taro Pharmaceuticals U.S.A., Inc..(Farnan, Kelly) |
| May 30, 2019 | 111 | Notice of Service (2) Docket Text: NOTICE OF SERVICE of 1) Zydus Pharmaceuticals (USA) Inc. and Cadila Healthcare Limiteds Fed. R. Civ. P. 26(a)(1) Initial Disclosures; and 2) Zydus Pharmaceuticals (USA) Inc. and Cadila Healthcare Limiteds Initial Disclosures Pursuant to Paragraph 3 of the Delaware Default Standard for Discovery filed by Cadila Healthcare Ltd., Zydus Pharmaceuticals (USA) Inc..(Braswell, Christine) |
| May 29, 2019 | N/A | SO ORDERED (0) |
| May 28, 2019 | 102 | Motion for Extension of Time (2) Docket Text: STIPULATION to Extend Deadlines - filed by Aurobindo Pharma Limited, Aurobindo Pharma USA, Inc.. (Dorsney, Kenneth) Modified on 5/29/2019 (nms). |
| May 1, 2019 | 101 | Scheduling Order (11) Docket Text: SCHEDULING ORDER: Case referred to the Magistrate Judge for the purpose of exploring ADR. Joinder of Parties due by 12/20/2019. Amended Pleadings due by 12/20/2019. Fact Discovery completed by 7/31/2020. Status Report due by 7/31/2020. Joint Claim Construction Brief due by 3/12/2020. A Markman Hearing is set for 4/13/2020, at 9:00 AM in Courtroom 6A. A Pretrial Conference is set for 3/26/2021, at 9:00 AM in Courtroom 6A. A 3-5 day Bench Trial is set to begin 4/12/2021, at 9:30 AM in Courtroom 6A (see Order for further details). Signed by Judge Richard G. Andrews on 4/30/2019. Associated Cases: 1:19-md-02884-RGA, 1:18-cv-01606-RGA, 1:18-cv-01673-RGA, 1:19-cv-00632-RGA(nms) |
| Apr 30, 2019 | 100 | Letter (1) |
| Apr 30, 2019 | 100 | Revised Proposed Scheduling Order (13) |
| Apr 30, 2019 | 100 | Main Document (1) Docket Text: Letter to The Honorable Richard G. Andrews from Megan E. Dellinger regarding Revised Proposed Scheduling Order. (Attachments: # (1) Revised Proposed Scheduling Order)(Dellinger, Megan) |
| Apr 25, 2019 | N/A | Scheduling Conference (0) Docket Text: Minute Entry for proceedings held before Judge Richard G. Andrews - Scheduling Conference held on 4/25/2019. Local counsel present for plaintiff: M. Dellinger. Local counsel present for defendants: P. Kraman, A. Gaza, K. Farnan, D. Moore, K. Mowery, N. Hoeschen, R. Touhey Myer, M. Haney, K. Harmon, K. Dorsney, S. Coyle. (Court Reporter Heather Triozzi.) Associated Cases: 1:19-md-02884-RGA, 1:18-cv-01606-RGA, 1:18-cv-01673-RGA, 1:19-cv-00632-RGA(crb) |
| Apr 24, 2019 | N/A | SO ORDERED (0) |
| Apr 23, 2019 | 98 | Letter (1) |
| Apr 23, 2019 | 98 | Proposed Order (13) |
| Apr 23, 2019 | 99 | Certification by Counsel (1) |
| Apr 23, 2019 | 98 | Main Document (1) Docket Text: Letter to The Honorable Richard G. Andrews from Megan E. Dellinger regarding Proposed Scheduling Order. (Attachments: # (1) Proposed Order)(Dellinger, Megan) Modified on 4/24/2019 (nms). |
| Apr 23, 2019 | 99 | Main Document (2) Docket Text: MOTION for Pro Hac Vice Appearance of Attorney John P. Snow - filed by Perrigo Company plc, Perrigo Pharma International DAC. (Attachments: # (1) Certification by Counsel)(Higgins, James) |
| Apr 22, 2019 | 97 | Notice of Appearance (2) Docket Text: NOTICE of Appearance by Christine M. Braswell on behalf of Cadila Healthcare Ltd., Zydus Pharmaceuticals (USA) Inc. (Braswell, Christine) |
| Apr 10, 2019 | N/A | Add Attorneys Pro Hac Vice (0) |
| Apr 9, 2019 | 96 | ANDA Form (3) Docket Text: Amended Supplemental information for patent cases involving an Abbreviated New Drug Application (ANDA) - Date Patentee(s) Received Notice: See Attached. Date of Expiration of Patent: August 16, 2026. (Dellinger, Megan) |
| Apr 8, 2019 | N/A | SO ORDERED (0) |
| Apr 8, 2019 | N/A | Add Attorneys Pro Hac Vice (0) |
| Apr 8, 2019 | 95 | Motion for Leave to Appear Pro Hac Vice (2) Docket Text: MOTION for Pro Hac Vice Appearance of Attorney Zaiba Baig - filed by Aleor Dermaceuticals Limited. (Harmon, Kate) |
| Apr 5, 2019 | N/A | Add Attorneys Pro Hac Vice (0) |
| Apr 5, 2019 | N/A | Oral Order (0) Docket Text: ORAL ORDER: A Scheduling Conference is now set for 4/25/2019, at 3:00 PM in Courtroom 6A before Judge Richard G. Andrews. The parties shall confer about scheduling and discovery limitations, and attempt to reach agreement. The parties shall use as a basis for discussion the Courts Rule 16 Scheduling Order patent, available on the Courts website. No later than 48 hours before the scheduling conference, the parties shall file a proposed scheduling order using the Rule 16 Scheduling Order - patent form. Ordered by Judge Richard G. Andrews on 4/5/2019. Associated Cases: 1:19-md-02884-RGA, 1:18-cv-01606-RGA, 1:18-cv-01673-RGA, 1:19-cv-00632-RGA(nms) |
| Apr 3, 2019 | N/A | Remark - MDL Member (0) Docket Text: NOTICE: Documents relating to all actions should be filed on the master docket sheet and on the docket sheet of each individual action. Documents relating to two or more, but not all, individual actions should be filed on the master docket sheet, and on the docket sheet of each affected individual action. Documents affecting a single individual action should be filed on the docket sheet of that action and on the master docket sheet. Associated Cases: 1:19-md-02884-RGA, 1:18-cv-01606-RGA, 1:18-cv-01673-RGA(rwc) |
| Apr 3, 2019 | 92 | Order (4) Docket Text: CERTIFIED TRANSFER ORDER - issued by the Panel on Multi-District Litigation on 4/3/19. Associated Cases: 1:19-md-02884-RGA, 1:18-cv-01606-RGA, 1:18-cv-01673-RGA(rwc) |
| Apr 3, 2019 | 93 | Remark - MDL Notice to Counsel (1) Docket Text: NOTICE TO COUNSEL: MDL No. 1:19-md-2884 has been opened and assigned to the Honorable Richard G. Andrews. Attorneys of record who will be electronically filing documents may use the attached form to register for a CM/ECF login and password. Please see the docket for further entries. Associated Cases: 1:19-md-02884-RGA, 1:18-cv-01606-RGA, 1:18-cv-01673-RGA(rwc) |
| Mar 26, 2019 | N/A | CORRECTING ENTRY: (0) |
| Mar 25, 2019 | 91 | Notice of Appearance (2) Docket Text: NOTICE of Appearance by Mary Kathryn Hodges Harmon on behalf of Aleor Dermaceuticals Limited (Harmon, Mary Kathryn) (Main Document 91 replaced on 3/26/2019) (nms). |
| Mar 1, 2019 | N/A | Oral Order (0) |
| Feb 8, 2019 | 89 | Request for Oral Argument (8) Docket Text: REQUEST for Oral Argument by Amneal Pharmaceuticals LLC re [46] Cross-Motion to Stay All Cases Against All Defendants and Response to Defendant Flatwing's Motion to Stay Case. (Gaza, Anne) Modified on 2/11/2019 (nms). |
| Feb 7, 2019 | 88 | Request for Oral Argument (1) Docket Text: REQUEST for Oral Argument by Aurobindo Pharma Limited, Aurobindo Pharma USA, Inc. re [46] Cross-Motion to Stay All Cases Against All Defendants and Response to Defendant Flatwing's Motion to Stay Case. (Dorsney, Kenneth) |
| Feb 6, 2019 | 87 | Answer to Counterclaim (14) Docket Text: ANSWER to [83] Answer to Complaint, Counterclaim by Anacor Pharmaceuticals, Inc..(Dellinger, Megan) |
| Feb 1, 2019 | 86 | Reply Brief (18) Docket Text: REPLY BRIEF re [46] Cross-Motion to Stay All Cases Against All Defendants and Response to Defendant Flatwing's Motion to Stay Case filed by Anacor Pharmaceuticals, Inc.. (Dellinger, Megan) |
| Jan 23, 2019 | 85 | Answer to Counterclaim (13) Docket Text: ANSWER to [69] Answer to Complaint, and Counterclaims, by Anacor Pharmaceuticals, Inc..(Dellinger, Megan) Modified on 1/24/2019 (nms). |
| Jan 18, 2019 | N/A | Add Attorneys Pro Hac Vice (0) |
| Jan 17, 2019 | N/A | Add Attorneys Pro Hac Vice (0) |
| Jan 16, 2019 | N/A | SO ORDERED (0) |
| Jan 16, 2019 | 83 | Answer to Complaint (100) |
| Jan 16, 2019 | 80 | Answer to Complaint (30) Docket Text: ANSWER to [1] Complaint, and Affirmative Defenses, by Cadila Healthcare Ltd., Zydus Pharmaceuticals (USA) Inc..(Kraman, Pilar) Modified on 1/16/2019 (nms). |
| Jan 16, 2019 | 81 | Disclosure Statement (3) Docket Text: Disclosure Statement pursuant to Rule 7.1: No Parents or Affiliates Listed filed by Cadila Healthcare Ltd.. (Kraman, Pilar) |
| Jan 16, 2019 | 82 | Disclosure Statement (3) Docket Text: Disclosure Statement pursuant to Rule 7.1: identifying Corporate Parent Cadila Healthcare Limited for Zydus Pharmaceuticals (USA) Inc. filed by Zydus Pharmaceuticals (USA) Inc.. (Kraman, Pilar) |
| Jan 16, 2019 | 83 | Exhibit 1 (45) |
| Jan 16, 2019 | 83 | Exhibit 2 (22) |
| Jan 16, 2019 | 84 | Disclosure Statement (4) Docket Text: Disclosure Statement pursuant to Rule 7.1: identifying Corporate Parent Amneal Pharmaceuticals, Inc., Corporate Parent APHC Holdings, LLC for Amneal Pharmaceuticals LLC filed by Amneal Pharmaceuticals LLC. (Gaza, Anne) |
| Jan 16, 2019 | 83 | Main Document (100) Docket Text: ANSWER to [1] Complaint, Affirmative Defenses, and COUNTERCLAIMS against Anacor Pharmaceuticals, Inc., by Amneal Pharmaceuticals LLC. (Attachments: # (1) Exhibit 1, # (2) Exhibit 2)(Gaza, Anne) Modified on 1/17/2019 (nms). |
| Jan 15, 2019 | 79 | Stipulation to EXTEND Time (5) Docket Text: STIPULATION and Proposed Order to Extend Time - filed by Anacor Pharmaceuticals, Inc.. (Dellinger, Megan) Modified on 1/16/2019 (nms). |
| Jan 11, 2019 | N/A | SO ORDERED (0) |
| Jan 11, 2019 | 78 | Motion for Leave to Appear Pro Hac Vice (7) Docket Text: MOTION for Pro Hac Vice Appearance of Attorney Michael J. Gaertner, Myoka Kim Goodin, Jonathan B. Turpin & Paul B. Sudentas - filed by Cadila Healthcare Ltd., Zydus Pharmaceuticals (USA) Inc.. (Kraman, Pilar) |
| Jan 9, 2019 | N/A | CORRECTING ENTRY: (0) |
| Jan 9, 2019 | 76 | Answering Brief in Opposition (25) |
| Jan 9, 2019 | 74 | Answering Brief in Opposition (9) Docket Text: ANSWERING BRIEF in Opposition re [46] Cross-Motion to Stay All Cases Against All Defendants and Response to Defendant Flatwing's Motion to Stay Case filed by Aurobindo Pharma Limited, Aurobindo Pharma USA, Inc..Reply Brief due date per Local Rules is 1/16/2019. (Dorsney, Kenneth) |
| Jan 9, 2019 | 75 | Notice of Appearance (2) Docket Text: NOTICE of Appearance by Pilar Gabrielle Kraman on behalf of Cadila Healthcare Ltd., Zydus Pharmaceuticals (USA) Inc. (Kraman, Pilar) (Main Document 75 replaced on 1/9/2019) (nms). |
| Jan 9, 2019 | 76 | Exhibit 1 (48) |
| Jan 9, 2019 | 77 | Response to Motion (4) Docket Text: RESPONSE to [46] Cross-Motion to Stay All Cases Against All Defendants and Response to Defendant Flatwing's Motion to Stay Case, filed by Aleor Dermaceuticals Limited. (Capuzzi, Kevin) Modified on 1/10/2019 (nms). |
| Jan 9, 2019 | 76 | Main Document (25) Docket Text: ANSWERING BRIEF in Opposition re [46] Cross-Motion to Stay All Cases Against All Defendants and Response to Defendant Flatwing's Motion to Stay Case filed by Amneal Pharmaceuticals LLC.Reply Brief due date per Local Rules is 1/16/2019. (Attachments: # (1) Exhibit 1)(Gaza, Anne) |
| Jan 7, 2019 | 72 | Answer to Counterclaim (13) Docket Text: ANSWER to [50] Answer to Complaint, and Counterclaims, by Anacor Pharmaceuticals, Inc..(Blumenfeld, Jack) Modified on 1/8/2019 (nms). |
| Jan 7, 2019 | 73 | Answer to Counterclaim (14) Docket Text: ANSWER to [53] Answer to Complaint, and Counterclaims, by Anacor Pharmaceuticals, Inc..(Blumenfeld, Jack) Modified on 1/8/2019 (nms). |
| Jan 4, 2019 | N/A | Add Attorneys Pro Hac Vice (0) |
| Jan 3, 2019 | N/A | SO ORDERED (0) |
| Jan 2, 2019 | 69 | Answer to Complaint (30) Docket Text: ANSWER to [1] Complaint, and COUNTERCLAIMS against Anacor Pharmaceuticals, Inc., by Perrigo Company plc, Perrigo Pharma International DAC.(Higgins, James) Modified on 1/2/2019 (nms). |
| Jan 2, 2019 | 70 | Disclosure Statement (2) Docket Text: Disclosure Statement pursuant to Rule 7.1: identifying Corporate Parent Perrigo Company plc for Perrigo Pharma International DAC, Perrigo Pharma International DAC filed by Perrigo Company plc, Perrigo Pharma International DAC. (Higgins, James) |
| Jan 2, 2019 | 71 | Motion for Leave to Appear Pro Hac Vice (5) Docket Text: MOTION for Pro Hac Vice Appearance of Attorney Steven M. Coyle, Andrew C. Ryan, and Nicholas A. Geiger - filed by Cipla Limited, Cipla USA, Inc.. (Cole, Jeremy) |
| Dec 27, 2018 | N/A | Add Attorneys Pro Hac Vice (0) |
| Dec 20, 2018 | N/A | Add Attorneys Pro Hac Vice (0) |
| Dec 19, 2018 | N/A | SO ORDERED (0) |
| Dec 19, 2018 | N/A | SO ORDERED (0) |
| Dec 19, 2018 | N/A | SO ORDERED (0) |
| Dec 19, 2018 | N/A | SO ORDERED (0) |
| Dec 19, 2018 | N/A | SO ORDERED (0) |
| Dec 19, 2018 | N/A | SO ORDERED (0) |
| Dec 19, 2018 | N/A | SO ORDERED (0) |
| Dec 19, 2018 | N/A | SO ORDERED (0) |
| Dec 19, 2018 | N/A | SO ORDERED (0) |
| Dec 19, 2018 | 67 | Stipulation to EXTEND Time (2) Docket Text: STIPULATION TO EXTEND TIME for Apotex to respond to Anacor's Cross Motion to Stay All Cases Against All Defendants (D.I. 46) to January 9, 2019 - filed by Apotex Corp., Apotex Inc.. (Haney, Megan) |
| Dec 19, 2018 | 68 | Stipulation to EXTEND Time (1) Docket Text: STIPULATION and Proposed Order to Extend Time - filed by Anacor Pharmaceuticals, Inc.. (Dellinger, Megan) Modified on 12/19/2018 (nms). |
| Dec 18, 2018 | N/A | SO ORDERED (0) |
| Dec 18, 2018 | N/A | Add Attorneys Pro Hac Vice (0) |
| Dec 18, 2018 | N/A | Add Attorneys Pro Hac Vice (0) |
| Dec 18, 2018 | N/A | Add Attorneys Pro Hac Vice (0) |
| Dec 18, 2018 | N/A | Add Attorneys Pro Hac Vice (0) |
| Dec 18, 2018 | N/A | Add Attorneys Pro Hac Vice (0) |
| Dec 18, 2018 | 62 | Stipulation to EXTEND Time (2) Docket Text: STIPULATION TO EXTEND TIME to respond to Motion to Stay to January 9, 2019 - filed by Ascent Pharmaceuticals, Inc.. (Myer, R.) Modified on 12/18/2018 (nms). |
| Dec 18, 2018 | 63 | Stipulation to EXTEND Time (3) Docket Text: STIPULATION and Proposed Order for Extension of Time to File Answer - filed by Cipla Limited, Cipla USA, Inc.. (Cole, Jeremy) Modified on 12/19/2018 (nms). |
| Dec 18, 2018 | 64 | Motion for Leave to Appear Pro Hac Vice (5) Docket Text: MOTION for Pro Hac Vice Appearance of Attorney Gary J. Speier, Samuel T. Lockner and Megan E. Hingtgen - filed by Taro Pharmaceutical Industries, Ltd., Taro Pharmaceuticals U.S.A., Inc.. (Farnan, Kelly) |
| Dec 18, 2018 | 65 | Motion for Extension of Time to File Response/Reply (2) Docket Text: STIPULATION and Proposed Order to Extend Time - filed by Aleor Dermaceuticals Limited. (Capuzzi, Kevin) Modified on 12/19/2018 (nms). |
| Dec 18, 2018 | 66 | Stipulation to EXTEND Time (2) Docket Text: STIPULATION and Proposed Order for Extension of Time to File Answer - filed by Taro Pharmaceutical Industries, Ltd., Taro Pharmaceuticals U.S.A., Inc.. (Farnan, Kelly) Modified on 12/19/2018 (nms). |
| Dec 17, 2018 | N/A | Add Attorneys Pro Hac Vice (0) |
| Dec 17, 2018 | N/A | CORRECTING ENTRY: (0) |
| Dec 17, 2018 | N/A | CORRECTING ENTRY: (0) |
| Dec 17, 2018 | N/A | SO ORDERED (0) |
| Dec 17, 2018 | N/A | CORRECTING ENTRY: (0) |
| Dec 17, 2018 | 50 | Answer to Complaint (117) |
| Dec 17, 2018 | 51 | Disclosure Statement (2) |
| Dec 17, 2018 | 50 | Certificate of Service (1) |
| Dec 17, 2018 | 51 | Certificate of Service (1) |
| Dec 17, 2018 | 52 | Motion for Leave to Appear Pro Hac Vice (3) Docket Text: MOTION for Pro Hac Vice Appearance of Attorney George J. Barry, III and Attorney Timothy H. Kratz - filed by Aurobindo Pharma Limited, Aurobindo Pharma USA, Inc.. (Dorsney, Kenneth) |
| Dec 17, 2018 | 53 | Answer to Complaint (30) Docket Text: ANSWER to [1] Complaint, Defenses, and COUNTERCLAIMS against Anacor Pharmaceuticals, Inc., by Cipla Limited, Cipla USA, Inc..(Cole, Jeremy) Modified on 12/17/2018 (nms). |
| Dec 17, 2018 | 54 | Disclosure Statement (3) Docket Text: Disclosure Statement pursuant to Rule 7.1: identifying filed by Cipla Limited. (Cole, Jeremy) Modified on 12/17/2018 (nms). |
| Dec 17, 2018 | 56 | Disclosure Statement (3) Docket Text: Disclosure Statement pursuant to Rule 7.1: identifying filed by Cipla USA, Inc.. (Cole, Jeremy) |
| Dec 17, 2018 | 57 | Certification by Counsel (3) |
| Dec 17, 2018 | 58 | Stipulation to EXTEND Time (2) Docket Text: STIPULATION for Extension of Time - filed by Aurobindo Pharma Limited, Aurobindo Pharma USA, Inc.. (Dorsney, Kenneth) Modified on 12/18/2018 (nms). |
| Dec 17, 2018 | 59 | Answer to Counterclaim (15) Docket Text: ANSWER to [35] Answer to Complaint, and Counterclaim, by Anacor Pharmaceuticals, Inc..(Dellinger, Megan) Modified on 12/18/2018 (nms). |
| Dec 17, 2018 | 60 | Answer to Counterclaim (11) Docket Text: ANSWER to [38] Answer to Complaint, and Counterclaims, by Anacor Pharmaceuticals, Inc..(Dellinger, Megan) Modified on 12/18/2018 (nms). |
| Dec 17, 2018 | 61 | Stipulation to EXTEND Time (2) Docket Text: STIPULATION for Extension of Time - filed by Amneal Pharmaceuticals LLC. (Vrana, Robert) Modified on 12/18/2018 (nms). |
| Dec 17, 2018 | 50 | Main Document (117) Docket Text: ANSWER to [1] Complaint, and COUNTERCLAIM against Anacor Pharmaceuticals, Inc., by Aleor Dermaceuticals Limited. (Attachments: # (1) Certificate of Service)(Capuzzi, Kevin) Modified on 12/17/2018 (nms). |
| Dec 17, 2018 | 51 | Main Document (2) Docket Text: Disclosure Statement pursuant to Rule 7.1: identifying Corporate Parent Alembic Pharmaceuticals Limited, Corporate Parent Orbicular Pharmaceutical Technologies Pvt Ltd. for Aleor Dermaceuticals Limited, Aleor Dermaceuticals Limited filed by Aleor Dermaceuticals Limited. (Attachments: # (1) Certificate of Service)(Capuzzi, Kevin) |
| Dec 17, 2018 | 57 | Main Document (2) Docket Text: MOTION for Pro Hac Vice Appearance of Attorney Gary E. Hood, Mark T. Deming, and Helena Berezowskyj - filed by Perrigo Company plc, Perrigo Pharma International DAC. (Attachments: # (1) Certification by Counsel)(Higgins, James) |
| Dec 14, 2018 | N/A | SO ORDERED (0) |
| Dec 13, 2018 | N/A | SO ORDERED (0) |
| Dec 13, 2018 | N/A | CORRECTING ENTRY: (0) |
| Dec 13, 2018 | N/A | SO ORDERED (0) |
| Dec 13, 2018 | 48 | Motion for Leave to Appear Pro Hac Vice (9) Docket Text: MOTION for Pro Hac Vice Appearance of Attorney Barry P. Golob, Esquire, Kerry B. McTigue, Esquire, W. Blake Coblentz, Esquire, Aaron S. Lukas, Esquire, and Keri L. Schaubert, Esquire - filed by Amneal Pharmaceuticals LLC. (Vrana, Robert) |
| Dec 13, 2018 | 49 | Motion for Leave to Appear Pro Hac Vice (2) Docket Text: MOTION for Pro Hac Vice Appearance of Attorney Michael S. Weinstein - filed by Aleor Dermaceuticals Limited. (Capuzzi, Kevin) |
| Dec 12, 2018 | 47 | Stipulation to EXTEND Time (2) Docket Text: STIPULATION TO EXTEND TIME to respond to the Cross Motion to Stay All Cases Against All Defendants (D.I. 46) to January 9, 2019 - filed by Perrigo Company plc, Perrigo Pharma International DAC. (Higgins, James) |
| Dec 10, 2018 | N/A | Set Answering Brief Deadline (0) Docket Text: Set Answering Brief Deadline re [46] Cross-Motion to Stay All Cases Against All Defendants and Response to Defendant Flatwing's Motion to Stay Case. Answering Brief/Response due date per Local Rules is 12/24/2018. (nms) |
| Dec 10, 2018 | 46 | Motion to Stay (12) Docket Text: Cross-Motion to Stay All Cases Against All Defendants and Response to Defendant Flatwing's Motion to Stay Case - filed by Anacor Pharmaceuticals, Inc.. (Dellinger, Megan) Modified on 12/11/2018 (nms). |
| Dec 7, 2018 | 44 | Answer to Counterclaim (11) Docket Text: ANSWER to [29] Answer to Complaint, and Counterclaim, by Anacor Pharmaceuticals, Inc..(Blumenfeld, Jack) Modified on 12/7/2018 (nms). |
| Dec 7, 2018 | 45 | Answer to Counterclaim (9) Docket Text: ANSWER to [30] Answer to Complaint, and Counterclaims, by Anacor Pharmaceuticals, Inc..(Blumenfeld, Jack) Modified on 12/7/2018 (nms). |
| Dec 5, 2018 | 43 | Summons Returned Executed (2) Docket Text: SUMMONS Returned Executed by Anacor Pharmaceuticals, Inc.. Cipla Limited served on 10/26/2018, answer due 11/16/2018. (Blumenfeld, Jack) |
| Dec 3, 2018 | N/A | CORRECTING ENTRY: (0) |
| Nov 30, 2018 | N/A | Add Attorneys Pro Hac Vice (0) |
| Nov 30, 2018 | N/A | SO ORDERED (0) |
| Nov 30, 2018 | 40 | Request for Waiver of Service (1) Docket Text: REQUEST FOR WAIVER of Service sent to Cadila Healthcare Ltd. on 11/14/2018 by Anacor Pharmaceuticals, Inc.. Waiver of Service due by 1/14/2019. (Dellinger, Megan) |
| Nov 30, 2018 | 41 | Waiver of Service Executed (1) Docket Text: WAIVER OF SERVICE returned executed by Anacor Pharmaceuticals, Inc.: For Cadila Healthcare Ltd. waiver sent on 11/14/2018, answer due 1/14/2019. (Dellinger, Megan) |
| Nov 30, 2018 | 42 | Stipulation to EXTEND Time (1) Docket Text: STIPULATION TO EXTEND TIME to answer, plead or otherwise respond to the Complaint to January 16, 2019 - filed by Anacor Pharmaceuticals, Inc.. (Dellinger, Megan) Modified on 12/3/2018 (nms). |
| Nov 26, 2018 | N/A | SO ORDERED (0) |
| Nov 26, 2018 | 35 | Answer to Complaint (30) Docket Text: ANSWER to [1] Complaint, and COUNTERCLAIMS against Anacor Pharmaceuticals, Inc., by Aurobindo Pharma USA, Inc., Aurobindo Pharma Limited.(Dorsney, Kenneth) Modified on 11/27/2018 (nms). |
| Nov 26, 2018 | 36 | Disclosure Statement (2) Docket Text: Disclosure Statement pursuant to Rule 7.1: identifying Corporate Parent Aurobindo Pharma Limited for Aurobindo Pharma USA, Inc. filed by Aurobindo Pharma Limited, Aurobindo Pharma USA, Inc.. (Dorsney, Kenneth) |
| Nov 26, 2018 | 37 | Patent/Trademark Report to Commissioner (1) Docket Text: Report to the Commissioner of Patents and Trademarks for Patent/Trademark Number(s) 7,582,621 B2 . (Dorsney, Kenneth) |
| Nov 26, 2018 | 38 | Answer to Complaint (30) Docket Text: ANSWER to [1] Complaint, and COUNTERCLAIMS against Anacor Pharmaceuticals, Inc., by Taro Pharmaceuticals U.S.A., Inc., Taro Pharmaceutical Industries, Ltd..(Farnan, Kelly) Modified on 11/27/2018 (nms). |
| Nov 26, 2018 | 39 | Disclosure Statement (2) Docket Text: Disclosure Statement pursuant to Rule 7.1: identifying Other Affiliate Sun Pharmaceutical Industries Ltd. for Taro Pharmaceutical Industries, Ltd., filed by Taro Pharmaceutical Industries, Ltd., Taro Pharmaceuticals U.S.A., Inc.. (Farnan, Kelly) Modified on 11/27/2018 (nms). |
| Nov 20, 2018 | N/A | SO ORDERED (0) |
| Nov 20, 2018 | 34 | Motion for Leave to Appear Pro Hac Vice (4) Docket Text: MOTION for Pro Hac Vice Appearance of Attorney Robert Silver and Salvatore Guerriero of Caesar Rivise, PC - filed by Ascent Pharmaceuticals, Inc.. (Myer, R.) |
| Nov 19, 2018 | N/A | SO ORDERED (0) |
| Nov 19, 2018 | 32 | Motion for Leave to Appear Pro Hac Vice (2) Docket Text: MOTION for Pro Hac Vice Appearance of Attorney Manish K. Mehta - filed by Aleor Dermaceuticals Limited. (Capuzzi, Kevin) |
| Nov 19, 2018 | 33 | Stipulation to EXTEND Time (1) Docket Text: STIPULATION TO EXTEND TIME to Answer complaint to November 30, 2018 - filed by Anacor Pharmaceuticals, Inc.. (Dellinger, Megan) |
| Nov 16, 2018 | N/A | SO ORDERED (0) |
| Nov 16, 2018 | N/A | Case Assigned/Reassigned (0) Docket Text: Case Reassigned to Judge Richard G. Andrews. Please include the initials of the Judge (RGA) after the case number on all documents filed. Associated Cases: 1:18-cv-01606-RGA, 1:18-cv-01673-RGA, 1:18-cv-01699-RGA (rjb) |
| Nov 16, 2018 | 28 | Affidavit of Service (9) Docket Text: AFFIDAVIT of Service for Summons, Complaint, and related papers served on Apotex Inc. on November 15, 2018, filed by Anacor Pharmaceuticals, Inc.. (Dellinger, Megan) |
| Nov 16, 2018 | 29 | Answer to Complaint (30) Docket Text: ANSWER to [1] Complaint with Affirmative Defenses, and COUNTERCLAIMS against Anacor Pharmaceuticals, Inc., by Ascent Pharmaceuticals, Inc..(Myer, R.) Modified on 11/16/2018 (nms). |
| Nov 16, 2018 | 30 | Answer to Complaint (30) Docket Text: ANSWER to [1] Complaint, Affirmative Defenses, and COUNTERCLAIMS against Anacor Pharmaceuticals, Inc., by Apotex Inc., Apotex Corp..(Phillips, John) Modified on 11/16/2018 (nms). |
| Nov 16, 2018 | 31 | Disclosure Statement (2) Docket Text: Disclosure Statement pursuant to Rule 7.1: identifying Corporate Parent Apotex Holdings, Inc. for Apotex Corp., Apotex Inc. filed by Apotex Corp., Apotex Inc.. (Phillips, John) |
| Nov 15, 2018 | N/A | SO ORDERED (0) |
| Nov 15, 2018 | N/A | SO ORDERED (0) |
| Nov 14, 2018 | 24 | Notice of Appearance (1) |
| Nov 14, 2018 | 23 | Stipulation to EXTEND Time (2) Docket Text: STIPULATION TO EXTEND TIME for Defendants Aurobindo Pharma Limited and Aurobindo Pharma USA, Inc. to answer, move or otherwise respond to the Complaint to November 26, 2018 - filed by Aurobindo Pharma Limited, Aurobindo Pharma USA, Inc.. (Dorsney, Kenneth) |
| Nov 14, 2018 | 24 | Certificate of Service (1) |
| Nov 14, 2018 | 25 | Stipulation to EXTEND Time (1) Docket Text: STIPULATION TO EXTEND TIME to Answer Complaint to December 17, 2018 - filed by Aleor Dermaceuticals Limited. (Capuzzi, Kevin) |
| Nov 14, 2018 | 26 | Stipulation to EXTEND Time (1) Docket Text: STIPULATION TO EXTEND TIME by which defendants Cipla Limited and Cipla USA, Inc. may respond to the Complaint to December 17, 2018 - filed by Anacor Pharmaceuticals, Inc.. (Dellinger, Megan) |
| Nov 14, 2018 | 27 | Stipulation to EXTEND Time (1) Docket Text: STIPULATION TO EXTEND TIME to respond to the Complaint to November 26, 2018 - filed by Taro Pharmaceutical Industries, Ltd., Taro Pharmaceuticals U.S.A., Inc.. (Farnan, Kelly) |
| Nov 14, 2018 | 24 | Main Document (1) Docket Text: NOTICE of Appearance by Kevin M. Capuzzi on behalf of Aleor Dermaceuticals Limited (Attachments: # (1) Certificate of Service)(Capuzzi, Kevin) |
| Nov 13, 2018 | 22 | Stipulation to EXTEND Time (2) Docket Text: STIPULATION TO EXTEND TIME for Defendant Amneal Pharmaceuticals LLC to answer the Complaint to January 16, 2019 - filed by Amneal Pharmaceuticals LLC. (Gaza, Anne) |
| Nov 5, 2018 | 18 | Request for Waiver of Service (1) Docket Text: REQUEST FOR WAIVER of Service sent to Perrigo Pharma International DAC on 11/2/2018 by Anacor Pharmaceuticals, Inc.. Waiver of Service due by 12/3/2018. (Blumenfeld, Jack) |
| Nov 5, 2018 | 19 | Waiver of Service Executed (1) Docket Text: WAIVER OF SERVICE returned executed by Anacor Pharmaceuticals, Inc.: For Perrigo Pharma International DAC waiver sent on 11/2/2018, answer due 1/2/2019. (Blumenfeld, Jack) |
| Nov 5, 2018 | 20 | Request for Waiver of Service (1) Docket Text: REQUEST FOR WAIVER of Service sent to Perrigo Company plc on 11/2/2018 by Anacor Pharmaceuticals, Inc.. Waiver of Service due by 12/3/2018. (Blumenfeld, Jack) |
| Nov 5, 2018 | 21 | Waiver of Service Executed (1) Docket Text: WAIVER OF SERVICE returned executed by Anacor Pharmaceuticals, Inc.: For Perrigo Company plc waiver sent on 11/2/2018, answer due 1/2/2019. (Blumenfeld, Jack) |
| Nov 2, 2018 | 16 | Notice of Appearance (3) Docket Text: NOTICE of Appearance by R. Touhey Myer on behalf of Ascent Pharmaceuticals, Inc. (Myer, R.) |
| Nov 2, 2018 | 17 | Disclosure Statement (1) Docket Text: Disclosure Statement pursuant to Rule 7.1: identifying Other Affiliate Hetero FZCO for Ascent Pharmaceuticals, Inc. filed by Ascent Pharmaceuticals, Inc.. (Myer, R.) |
| Nov 1, 2018 | N/A | CORRECTING ENTRY: (0) |
| Nov 1, 2018 | N/A | SO ORDERED (0) |
| Oct 31, 2018 | N/A | Case Assigned/Reassigned (0) |
| Oct 31, 2018 | 12 | Declaration (9) Docket Text: DECLARATION of Mailing to Perrigo Pharma International DAC, by Anacor Pharmaceuticals, Inc.. (Dellinger, Megan) Modified on 11/28/2018 (nms). |
| Oct 31, 2018 | 13 | Declaration (9) Docket Text: DECLARATION of Mailing to Zydus Pharmaceuticals (USA) Inc., by Anacor Pharmaceuticals, Inc.. (Dellinger, Megan) Modified on 11/28/2018 (nms). |
| Oct 31, 2018 | 15 | Motion for Leave to Appear Pro Hac Vice (7) Docket Text: MOTION for Pro Hac Vice Appearance of Attorney Aaron P. Maurer, David I. Berl, David M. Horniak and Anthony Sheh of Williams & Connolly LLP - filed by Anacor Pharmaceuticals, Inc.. (Dellinger, Megan) |
| Oct 29, 2018 | 6 | Summons Returned Executed (2) Docket Text: SUMMONS Returned Executed by Anacor Pharmaceuticals, Inc.. Amneal Pharmaceuticals LLC served on 10/26/2018, answer due 11/16/2018. (Blumenfeld, Jack) |
| Oct 29, 2018 | 7 | Summons Returned Executed (2) Docket Text: SUMMONS Returned Executed by Anacor Pharmaceuticals, Inc.. Apotex Corp. served on 10/26/2018, answer due 11/16/2018. (Blumenfeld, Jack) |
| Oct 29, 2018 | 8 | Summons Returned Executed (2) Docket Text: SUMMONS Returned Executed by Anacor Pharmaceuticals, Inc.. Ascent Pharmaceuticals, Inc. served on 10/26/2018, answer due 11/16/2018. (Blumenfeld, Jack) |
| Oct 29, 2018 | 9 | Summons Returned Executed (2) Docket Text: SUMMONS Returned Executed by Anacor Pharmaceuticals, Inc.. Aurobindo Pharma USA, Inc. served on 10/26/2018, answer due 11/16/2018. (Blumenfeld, Jack) |
| Oct 29, 2018 | 10 | Summons Returned Executed (2) Docket Text: SUMMONS Returned Executed by Anacor Pharmaceuticals, Inc.. Cipla USA, Inc. served on 10/26/2018, answer due 11/16/2018. (Blumenfeld, Jack) |
| Oct 29, 2018 | 11 | Summons Returned Executed (2) Docket Text: SUMMONS Returned Executed by Anacor Pharmaceuticals, Inc.. Taro Pharmaceuticals U.S.A., Inc. served on 10/26/2018, answer due 11/16/2018. (Blumenfeld, Jack) |
| Oct 25, 2018 | N/A | Summons Issued (0) Docket Text: Summons Issued with Magistrate Consent Notice attached as to Aleor Dermaceuticals Limited on 10/25/2018; Amneal Pharmaceuticals LLC on 10/25/2018; Apotex Corp. on 10/25/2018; Apotex Inc. on 10/25/2018; Ascent Pharmaceuticals, Inc. on 10/25/2018; Aurobindo Pharma Limited on 10/25/2018; Aurobindo Pharma USA, Inc. on 10/25/2018; Cadila Healthcare Ltd. on 10/25/2018; Cipla Limited on 10/25/2018; Cipla USA, Inc. on 10/25/2018; Perrigo Company plc on 10/25/2018; Perrigo Pharma International DAC on 10/25/2018; Taro Pharmaceutical Industries, Ltd. on 10/25/2018; Taro Pharmaceuticals U.S.A., Inc. on 10/25/2018; Zydus Pharmaceuticals (USA) Inc. on 10/25/2018. Requesting party or attorney should pick up issued summons at the Help Desk, Room 4209, or call 302-573-6170 and ask the Clerk to mail the summons to them. (nmg) |
| Oct 25, 2018 | 1 | Complaint (78) |
| Oct 25, 2018 | 1 | Exhibit A-D (961) |
| Oct 25, 2018 | 1 | Civil Cover Sheet (1) |
| Oct 25, 2018 | 2 | Magistrate Consent Forms (3) Docket Text: Notice, Consent and Referral forms re: U.S. Magistrate Judge jurisdiction. (nmg) |
| Oct 25, 2018 | 3 | ANDA Form (3) Docket Text: Supplemental information for patent cases involving an Abbreviated New Drug Application (ANDA) - Date Patentee(s) Received Notice: SEE ATTACHED. Date of Expiration of Patent: 2/16/2026. (nmg) |
| Oct 25, 2018 | 4 | Patent/Trademark Report to Commissioner (1) Docket Text: Report to the Commissioner of Patents and Trademarks for Patent/Trademark Number(s) 9,459,938 B2 ;9,566,289 B2 ;9,566,290 B2 ;9,572,823 B2. (nmg) |
| Oct 25, 2018 | 5 | Disclosure Statement (2) Docket Text: Disclosure Statement pursuant to Rule 7.1: No Parents or Affiliates Listed filed by Anacor Pharmaceuticals, Inc. (nmg) |
| Oct 25, 2018 | 1 | Main Document (78) Docket Text: COMPLAINT for PATENT INFRINGEMENT filed against Aleor Dermaceuticals Limited, Amneal Pharmaceuticals LLC, Apotex Corp., Apotex Inc., Ascent Pharmaceuticals, Inc., Aurobindo Pharma Limited, Aurobindo Pharma USA, Inc., Cadila Healthcare Ltd., Cipla Limited, Cipla USA, Inc., Perrigo Company plc, Perrigo Pharma International DAC, Taro Pharmaceutical Industries, Ltd., Taro Pharmaceuticals U.S.A., Inc., Zydus Pharmaceuticals (USA) Inc. - Magistrate Consent Notice to Pltf. ( Filing fee $ 400, receipt number 0311-2489591.) - filed by Anacor Pharmaceuticals, Inc.. (Attachments: # (1) Exhibit A-D, # (2) Civil Cover Sheet)(nmg) |
